Prof. Dr. Michael Hust

Michael studied biology at the Carl von Ossietzky Universität in Oldenburg, Germany, from 1993-1999. He received his PhD from the Leibniz Universität in Hannover, Germany, in 2002. Since end of 2002 he is working as group leader at the Technische Universität Braunschweig, Germany. In 2011, he finished his professorial dissertation (Habilitation) and was appointed as Privatdozent (PD). In 2014 he was appointed as professor for biotechnology and in 2022 he became head of the Medical Biotechnology department. Michael published more than 170 articles and filed several patents in the field of antibody engineering and phage display. He is co-author of the German text book „Rekombinante Antikörper“ and editor of the book „Phage Display“. His research passion is the development of recombinant antibodies and antibody engineering for diagnostics and therapy with a focus on infectious diseases and toxins as well as the identification of biomarkers of pathogens using ORFeome phage display. He co-founded four biotech companies including YUMAB GmbH and CORAT Therapeutics.